Natalia Higuita‐Castro

Natalia Higuita-Castro's research focuses on engineering extracellular vesicles (tiny cell-derived particles that carry molecules like proteins and RNA) and using nanotechnology-based gene delivery methods to repair or reprogram tissues, with applications ranging from wound healing and nerve injury repair to lung injury, cancer immunotherapy, and spinal disc disease. Her lab develops tools such as tissue nanotransfection (a technique that reprograms skin cells in place using tiny needle arrays) and lab-on-a-chip devices to study and treat disease. This work sits at the intersection of biomedical engineering, regenerative medicine, and molecular biology, aiming to translate cell and gene therapies into practical clinical tools.

Publication output rose steadily from 2017 to a peak in 2020, then leveled off to a moderate, fluctuating pace of roughly 4-6 papers per year through 2024, with a gap in 2025 and new entries appearing for 2026.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026